Uridax-0.4 Tablets provide an established, clinically unified urological therapy carefully developed for the continuous management and physiological stabilization of symptomatic Benign Prostatic Hyperplasia (BPH). When the prostate gland enlarges non-malignantly over time, it physically compresses the urethral channel running through it. This mechanical constriction restricts the normal voiding of urine, leading to painful straining, a weak or hesitating stream, a constant feeling of incomplete emptying, and intense urinary urgency. This advanced formulation delivers a selective blocker within a smooth modified-release matrix, ensuring steady, 24-hour muscle relaxation directly targeting bladder neck tissues safely over a long-term care routine.
The active component, Tamsulosin Hydrochloride (0.4 mg), functions dynamically via highly targeted cellular tracks:
-
Selective Adrenoreceptor Antagonism: It operates as a highly potent, selective antagonist of alpha-1 ($\alpha_1$) adrenoreceptors, showing supreme affinity specifically for the $\alpha_{1\text{A}}$ and $\alpha_{1\text{D}}$ receptor subtypes concentrated heavily within human prostate tissue, prostatic urethra, and the bladder neck muscle layer.
-
Vascular-Sparing Muscle Relaxation: By blocking sympathetic adrenaline signaling at these specific nodes, it safely decreases smooth muscle tone in the prostate and bladder outlet pathways without causing significant systemic vasodilation or dropping peripheral blood pressure baseline values. This process widens the blocked urethral passage, dropping mechanical resistance to clear urinary flow channels smoothly around the clock.
Key Benefits
-
Targeted Prostate Muscle Calm: Relaxes localized tissue tension specifically to minimize painful straining and urine hesitation loops.
-
Restores Strong Urine Stream: Mechanically clears blockages to help empty the bladder completely, supporting normal, healthy urinary mechanics.
-
Reduces Nighttime Disruptions: Calms over-reactive bladder urgency markers to decrease frequent nighttime awakenings and support better rest.
-
Modified-Release Stability: The advanced tablet matrix releases active therapeutic components slowly over 24 hours, dropping the risk of sudden medicinal tracking drops.
-
Trusted Quality Formulation: Manufactured under high-standard pharmaceutical guidelines of DH, ensuring exceptional active component purity and steady structural bio-availability.
Directions for Use
-
Take exactly as directed by your urologist or primary care physician.
-
Uridax-0.4 must strictly be taken orally once daily, approximately 30 minutes following the exact same meal every day (preferably right after breakfast or your first meal of the day). Taking it with food stabilizes absorption tracking baselines.
-
Swallow the tablet whole with a full glass of plain water. Do not crush, break, split, or chew it, as doing so will destroy the modified-release design and cause rapid medicine dumping.
-
Maintain complete daily consistency; missing doses can cause localized muscle rigidity to return behind tracking baselines.
Safety & Precautions
-
Do not modify your dose or halt usage suddenly without professional medical instruction, as urinary obstruction symptoms can return rapidly.
-
Intended Exclusively for Male Patients: This medication is indicated primarily for the treatment of enlarged prostate symptoms in adult men; it is not formulated or approved for female or pediatric medical profiles.
-
Initial Dizziness Warning (First-Dose Effect): Tamsulosin can occasionally cause a sudden drop in blood pressure when changing positions, leading to mild dizziness or fainting, especially during the first few days of starting treatment or following a dose adjustment. Avoid driving or operating complex machinery if you experience these parameters.
-
Inform your specialist before initialization if you have an underlying history of severe liver impairment, advanced kidney vulnerabilities, or orthostatic hypotension.
-
Cataract Surgery Alert (IFIS): If you are scheduled to undergo cataract or glaucoma surgery, explicitly inform your eye surgeon/ophthalmologist that you are taking Uridax-0.4. This medicine can cause a complication known as Intraoperative Floppy Iris Syndrome (IFIS) during the operation, which the surgeon needs to prepare for.
-
Keep out of reach of children.
Storage
-
Store in a cool, dry place below 30°C.
-
Protect from direct sunlight, excessive heat sources, and ambient environmental room moisture pools.
-
Keep the tablets safely stored inside their original protective blister packaging layout until the exact second of consumption to safeguard the modified-release core components.
